这些满足适应症的患者被随机分至单用吉西他滨组(204例)和顺铂-吉西他滨联用组(206例)。
Eligible patients were randomized to either treatment with gemcitabine alone (204 participants) or in combination with cisplatin (206).
这些满足适应症的患者被随机分至单用吉西他滨组(204例)和顺铂-吉西他滨联用组(206例)。
Eligible patients were randomized to either treatment with gemcitabine alone (204 participants) or in combination with cisplatin (206).
应用推荐